XR Humerus Views 28567-6
LOINC Code
LOINC code | 28567-6 | ||||
---|---|---|---|---|---|
name | XR Humerus Views | ||||
status | ACTIVE | ||||
Fully-Specified Name | |||||
component | Views | ||||
property | Find = Finding | ||||
time | Pt = Point in time: To identify measures at a point in time. This is a synonym for “spot” or “random” as applied to urine measurements. | ||||
system | Upper extremity>Humerus | ||||
scale | Doc = Document: A document that could be in many formats (XML, narrative, etc.) | ||||
method | XR | ||||
Additional Names | |||||
short name | XR Humerus Views | ||||
Basic Attributes | |||||
class | RAD | ||||
type | 2 Clinical | ||||
order vs. observation | Both | ||||
Ask At Order Entry | |||||
Ask at Order Entry (AOE) observations for a clinical observation or laboratory test. A LOINC term may represent a single AOE observation or a panel containing several AOE observations.
| |||||
Associated Observations | |||||
LOINC codes that represent optional associated observation(s) for a clinical observation or laboratory test. A LOINC term may represent a single associated observation or panel containing several associated observations. | |||||
Member of these Groups | |||||
| |||||
Member of these Panels | |||||
| |||||
History/Usage | |||||
test rank | 7861 of 2000 most commonly performed tests by labs in USA | ||||
first released | |||||
last updated | 2.73 | ||||
last change type | MIN - change to field other than name | ||||
change reason | The scale has been changed from "Nar" to "Doc" to fit with the CDA model.; Updated System from "Humerus" per LOINC/RadLex unified model | ||||
Related Names | |||||
|
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.
Thank you for choosing Find-A-Code, please Sign In to remove ads.